Ken Cheng

Ken Cheng has extensive work experience in the pharmaceutical industry. Ken is currently working as an Associate Director of Clinical Operations at Arbele since 2023. Prior to this, they worked at Amgen from 2016 to 2023, where they held various roles including Senior Development Operations Manager for SE Asia & Taiwan and Clinical Operations and Oversight Manager for the SEA Hub including Taiwan. Before joining Amgen, they worked at Novartis HK as the GMO Country Head from 2013 to 2016. Ken also has experience at Novartis Oncology as a CRA Group Manager from 2011 to 2013. Ken's early career started at Roche Pharmaceuticals, where they worked as a Clinical Research Manager from 2005 to 2011.

Ken Cheng holds a Master of Philosophy (MPhil) degree in Physiology from The Chinese University of Hong Kong.